Blood Transfusion Diagnostics Market Expects to Worth Over USD 2.45 Bn by Renowned Players and Business Insights to 2023

Blood Transfusion Diagnostics Market research report added by Garner Insights covers market overview, which defines market dynamics, economic impact regionally and internationally, competition by manufactures, supply and demand analysis, and production and consumption analysis.

Pune, India - June 13, 2019 /MarketersMedia/ —

The Global Blood Transfusion Diagnostics Market is expected to rise to valuation of USD 2.45 billion by 2023, rising at a CAGR of 8.2% over its 2016 value of USD 1.5 billion, according to the latest research report from Market Research Future (MRFR). The global blood transfusion diagnostics market is mainly driven by the growing demand for blood transfusions and the growing demand for ensuring safe blood transfusions. The global blood transfusion diagnostics market is assessed in great detail in the report, which provides a thorough review of the market’s key drivers and restraints, leading segments, and major market players.

Get Free Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/1126

The Global Blood Transfusion Diagnostics Market is mainly driven by the growing demand for blood transfusions. The blood transferred during blood transfusions has to be checked for diseases before being transferred to another patient, as bloodborne diseases can be contracted by the recipient. This has led to a growing demand for strong blood transfusion diagnostics infrastructure. In developed regions, the blood transfusion diagnostics infrastructure is widespread and strong due to the high number of blood transfusion procedures carried out in these regions. The receiver of the blood as well as the medical staff are susceptible to diseases contained in donated blood, making it likely that the blood transfusion diagnostics market will grow at a stable growth rate over the forecast period.

The increasing prevalence of infectious diseases and the growing awareness about the need for effective blood transfusion diagnostics are also likely to be major drivers for the global blood transfusion diagnostics market over the forecast period. Infectious diseases are a major concern for the global healthcare sector, making it likely that the global blood transfusion diagnostics market will receive stable government support over the coming years, leading to steady growth of the market.

Industry News:

In February 2019, a two year old in the Tamil Nadu state of India was alleged to have contracted HIV from a blood transfusion. Further enquiries cleared the hospital staff of any wrongdoing, as the source of the HIV was ascertained to be something other than the transfusion. Such incidents reveal the need for strong blood transfusion diagnostics infrastructure, especially in emerging countries.

Key Players - Blood Transfusion Diagnostics Market

Grifols,
Roche Diagnostics,
Bio-Rad Laboratories Inc.,
Siemens Healthineers,
Becton Dickinson and Company,
Beckman Coulter Inc.,
Diagast,
BAG Healthcare,
Fujirebio,
Quidel,
Biokit,
Hologic/Gen-Probe,
DiaSorin,
Abbott Diagnostics,
Ortho Clinical Diagnostics,
Novartis AG,
Immucor,
bioMerieux, and
Thermo Fisher Scientific Inc.

Segments - Blood Transfusion Diagnostics Market

The global blood transfusion diagnostics market is segmented on the basis of blood product, technology, end user, and region.

By blood product, the global blood transfusion diagnostics market includes red blood cells, platelets, plasma, albumin, immunoglobulin preparations, and other products.

On the basis of technology, the blood transfusion diagnostics market is segmented into Western Blot, ELISA, nucleic acid amplification, fluorescence assay, rapid test, and other technologies. ELISA is further segmented into chemiluminescence immunoassay (CLIA), fluorescence immunoassays (FIA), and colorimetric immunoassay (CI). The nucleic acid amplification segment is further sub-segmented into thermomechanical analysis (TMA) and real-time PCR. The nucleic acid amplification segment is likely to be dominant in the global blood transfusion diagnostics market over the forecast period. The segment held a share of more than 60% in the global blood transfusion diagnostics market in 2016.

End users in the global blood transfusion diagnostics market include hospitals, clinics, blood banks, and laboratories.

Browse Complete Report visit https://www.marketresearchfuture.com/reports/blood-transfusion-diagnostics-market-1126

Regional Analysis - Blood Transfusion Diagnostics Market

The global blood transfusion diagnostics market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa. The Americas segment is expected to retain the dominant share in the global blood transfusion diagnostics market over the forecast period due to the growing blood transfusion diagnostics infrastructure in the region and the growing support given by government bodies for blood transfusion processes. Europe also holds a significant share in the global blood transfusion diagnostics market, while Asia Pacific is expected to exhibit rapid growth in the market over the forecast period due to steady growth of the healthcare sector in APAC countries.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Info:
Name: Market Research Future
Email: Send Email
Organization: Market Research Future
Address: Office No. 528, Amanora Chambers, Magarpatta Road, Hadapsar, Pune – 411028, Maharashtra, India
Phone: +1 646 845 9312
Website: https://www.marketresearchfuture.com/reports/blood-transfusion-diagnostics-market-1126

Source URL: https://marketersmedia.com/blood-transfusion-diagnostics-market-expects-to-worth-over-usd-245-bn-by-renowned-players-and-business-insights-to-2023/523874

Source: MarketersMedia

Release ID: 523874

More News From The World Agenda

Stocks rise as China confirms trade deal signing next week

Jul 16, 2020

NEW YORK — U.S stocks climbed in morning trading on Thursday as investors cheered confirmation from China that its top trade official will head to Washington next week to sign a preliminary trade deal. The “Phase 1” accord is the opening step on a possible path toward a broader agreement between the nations. President Donald Trump has said he will travel to Beijing after the initial signing to start the second stage of talks. Every major index is on track for a record as Wall Street distances itself from a bout of anxiety over the last week because of tensions...

Counting whales from space pitched as key to saving them

Jul 16, 2020

PORTLAND, Maine — An aquarium and an engineering firm in Massachusetts are partnering on a project to better protect whales by monitoring them from space. New England Aquarium of Boston and Draper of Cambridge say whale conservation needs new, higher-tech solutions to protect whales from extinction. So, the pair is working together using data from sources such as satellites, sonar and radar to keep a closer eye on how many whales are in the ocean. The effort has an easy to understand name for a project involving complex data and surveillance — the aquarium and firm are calling the project...

US heads to court to build Trump border wall in Texas

Jul 16, 2020

HOUSTON — Three years into Donald Trump's presidency, the U.S. government is ramping up its efforts to seize private land in Texas to build a border wall. Trump's signature campaign promise has consistently faced political, legal, and environmental obstacles in Texas, which has the largest section of the U.S.-Mexico border, most of it without fencing. And much of the land along the Rio Grande, the river that forms the border in Texas, is privately held and environmentally sensitive. Almost no land has been taken so far. But Department of Justice lawyers have filed three lawsuits this month seeking to take...

Space Force will start small but let Trump claim a big win

Jul 16, 2020

WASHINGTON — The Trump administration is celebrating the launch of Space Force, the first new military service in more than 70 years. In signing the 2020 National Defense Authorization Act that includes Space Force, Trump on Friday can claim a victory for one of his top national security priorities just two days after being impeached by the House. It is part of a $1.4 trillion government spending package — including the Pentagon's budget — that provides a steady stream of financing for Trump's U.S.-Mexico border fence and reverses unpopular and unworkable automatic spending cuts to defense and domestic programs. Space...

House passes $1.4T government spending bill amid impeachment

Jul 16, 2020

WASHINGTON — The Democratic-controlled House voted Tuesday to pass a $1.4 trillion government spending package, handing President Donald Trump a victory on his U.S.-Mexico border fence while giving Democrats spending increases across a swath of domestic programs. The hard-fought legislation also funds a record Pentagon budget and is serving as a must-pass legislative locomotive to tow an unusually large haul of unrelated provisions into law, including an expensive repeal of Obama-era taxes on high-cost health plans, help for retired coal miners, and an increase from 18 to 21 in the nationwide legal age to buy tobacco products. The two-bill package,...

Here at The World Agenda, we bring innovation to digital news for you to keep abreast of worldwide news instantly anywhere.

Contact us: sales[at]theworldagenda.com